These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10890477)

  • 1. The effect of heparin-coated pulmonary artery catheters on activated coagulation time in cardiac surgical patients.
    Haering JM; Maslow AD; Parker RA; Lowenstein E; Comunale ME
    J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):260-3. PubMed ID: 10890477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass.
    Guzzetta NA; Monitz HG; Fernandez JD; Fazlollah TM; Knezevic A; Miller BE
    Anesth Analg; 2010 Jul; 111(1):173-9. PubMed ID: 20519414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaolin-based activated coagulation time measured by sonoclot in patients undergoing cardiopulmonary bypass.
    Ganter MT; Monn A; Tavakoli R; Klaghofer R; Zollinger A; Hofer CK
    J Cardiothorac Vasc Anesth; 2007 Aug; 21(4):524-8. PubMed ID: 17678778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison between arterial- and venous-sampled activated clotting time measurements.
    Zisman E; Rozenberg B; Katz Y; Ziser A
    Isr J Med Sci; 1997 Dec; 33(12):786-8. PubMed ID: 9464347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of heparin-bonded pulmonary artery catheters on the activated coagulation time.
    McNulty SE; Maguire DP; Thomas RE
    J Cardiothorac Vasc Anesth; 1998 Oct; 12(5):533-5. PubMed ID: 9801973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arterial versus venous sampling for activated coagulation time measurements during cardiac surgery: a comparative study.
    Leyvi G; Zhuravlev I; Inyang A; Vinluan J; Ramachandran S; Lehning EJ; Wasnick JD
    J Cardiothorac Vasc Anesth; 2004 Oct; 18(5):573-80. PubMed ID: 15578467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
    Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery.
    Oliver WC; Nuttall GA; Ereth MH; Santrach PJ; Buda DA; Schaff HV
    J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):165-70. PubMed ID: 12698396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discard volumes necessary for clinically useful coagulation studies from heparinized Hickman catheters.
    Mayo DJ; Dimond EP; Kramer W; Horne MK
    Oncol Nurs Forum; 1996 May; 23(4):671-5. PubMed ID: 8735325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparinized saline versus normal saline in maintaining patency of the radial artery catheter.
    Kulkarni M; Elsner C; Ouellet D; Zeldin R
    Can J Surg; 1994 Feb; 37(1):37-42. PubMed ID: 8306218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated clotting time tests with heparinase in the management of pediatric patients on cardiopulmonary bypass.
    Kriesmer P; Payne NR; Tessmer J; Uden DL
    ASAIO J; 1993; 39(4):942-5. PubMed ID: 8123932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulopathy screening in children with heparinized central venous catheters.
    Ellis MR
    Pediatrics; 1993 Jun; 91(6):1147-50. PubMed ID: 8502518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery.
    Taneja R; Marwaha G; Sinha P; Quantz M; Stitt L; Gao R; Subramanian S; Schaus M; Keeney M; Chin-Yee I; Murkin J
    Can J Anaesth; 2009 Jul; 56(7):489-96. PubMed ID: 19408066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between heparin level and activated clotting time in the adult cardiac surgery population.
    Fitzgerald DJ; Patel A; Body SC; Garvin S
    Perfusion; 2009 Mar; 24(2):93-6. PubMed ID: 19654150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activated coagulation time: suitability for monitoring heparin effect and neutralization during pediatric cardiac surgery.
    Martindale SJ; Shayevitz JR; D'Errico C
    J Cardiothorac Vasc Anesth; 1996 Jun; 10(4):458-63. PubMed ID: 8776637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
    Kim YS; Murkin JM; Adams SJ
    Heart Surg Forum; 2004; 7(6):E599-604. PubMed ID: 15769695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing systems for measuring activated clotting times: impact on the clinical practice of heparin anticoagulation during cardiac surgery.
    Patteril M; Stafford-Smith M; Toffaletti JG; Bute BP; Milano CA; Welsby IJ
    Clin Chim Acta; 2005 Jun; 356(1-2):218-24. PubMed ID: 15936321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of activated coagulation time in children: evaluation of the blood-saving kaolin i-STAT activated coagulation time technique in pediatric cardiac anesthesia.
    Ulmer FF; Baulig W; Béttex D; Spielmann N; Bürki C; Weiss M
    J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):395-401. PubMed ID: 21376632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.